School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Curr Med Sci. 2019 Jun;39(3):349-355. doi: 10.1007/s11596-019-2042-2. Epub 2019 Jun 17.
Peptides play crucial roles in various physiological and pathological processes. Consequently, the investigation of peptide-based drugs is a highlight in the research and development of new drugs. However, natural peptides are not always ideal choices for clinical application due to their limited number and sometimes cytotoxicity to normal cells. Aiming to gain stronger or specific or novel biological effects and overcome the disadvantages of natural peptides, artificial hybrid peptides have been designed by combining the sequence of two or more different peptides with varied biological functions. Compared to natural peptides, hybrid peptides have shown better therapeutic potentials against bacteria, tumors, and metabolic diseases. In this review, design strategies, structure features and recent development of hybrid peptides are summarized; future directions for the research and development of hybrid peptide drugs are also discussed.
肽在各种生理和病理过程中起着至关重要的作用。因此,基于肽的药物的研究是新药研发的一个重点。然而,由于天然肽的数量有限,有时对正常细胞具有细胞毒性,它们并不总是临床应用的理想选择。为了获得更强、更特异或新颖的生物学效应,并克服天然肽的缺点,人工杂合肽已经通过将两个或更多具有不同生物学功能的不同肽的序列组合而设计出来。与天然肽相比,杂合肽在对抗细菌、肿瘤和代谢疾病方面显示出更好的治疗潜力。本文综述了杂合肽的设计策略、结构特征和最新进展,并讨论了杂合肽药物研发的未来方向。